Skip to content

US · PNTG · MEDICAL - CARE FACILITIES

The Pennant Group, Inc. (PNTG) intrinsic value and stock valuation

$34.64as of 2026-11-21 · Mkt cap 1.35B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

The Pennant Group, Inc. DCF and intrinsic value

InvestorsCraft values PNTG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from PNTG’s statements →

The Pennant Group, Inc. Graham Number

Graham Number: $14.44d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Eagle, ID 83616 pennantgroup.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$947.7M+19.4% 5y CAGRd
20162025
Net income
$29.6M+13.4% 5y CAGRd
20162025
Free cash flow
$26.3M-9.3% 5y CAGRd
20162025
Total equity
$374.3M+29.9% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$947.7M$695.2M$544.9M$473.2M$439.7M
Operating income$51.4M$38.1M$25.2M$12.7M$4.7M
Net income$29.6M$22.6M$13.4M$6.64M$2.7M
EPSd$837.5K$705K$443.2K$220.2K$88.1K
Operating cash flow$48.3M$39.3M$33.1M$9.04M-$-18.22M
Capital expenditure-$-22M-$-8.99M-$-8.11M-$-14.17M-$-6.3M
Free cash flow$26.3M$30.3M$25M-$-5.13M-$-24.53M
Total assets$968.2M$679.5M$539.7M$512.1M$530.3M
Total debt$453.2M$273.1M$329.6M$326.6M$355.2M
Net debt$436.1M$248.8M$323.6M$324.5M$350.1M
Total equity$374.3M$312M$145.5M$125.7M$114.2M
Cash and short-term investments$17M$24.3M$6.06M$2.08M$5.19M
Income statement
20252024202320222021
Revenue$947.7M$695.2M$544.9M$473.2M$439.7M
Cost of revenue$825.2M$601.5M$477.9M$414.7M$391.1M
Gross profit$122.5M$93.8M$67M$58.6M$48.6M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$71.1M$50.2M$36.7M$34M$36.3M
Other expenses$0.00$5.44M$5.2M$11.9M$7.64M
Operating expenses$71.1M$55.7M$41.9M$45.9M$43.9M
Cost and expenses$896.3M$657.1M$519.7M$460.5M$435M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$6.68M$6.96M$5.92M$3.82M$1.94M
Depreciation and amortization$8.54M$6.12M$5.13M$4.9M$4.78M
Ebitda$60.9M$44.4M$30.6M$17.6M$9.46M
Operating income$51.4M$38.1M$25.2M$12.7M$4.7M
Total other income/expenses, net-$-5.76M-$-6.75M-$-5.58M-$-3.85M-$-1.97M
Income before tax$45.6M$31.4M$19.6M$8.89M$2.73M
Income tax expense$11.9M$7.03M$5.67M$1.65M$580K
Net income$29.6M$22.6M$13.4M$6.64M$2.7M
Weighted average shares outstanding$34.6M$31.2M$29.9M$29.1M$28.4M
Weighted average diluted shares outstanding$35.3M$32M$30.2M$30.2M$30.6M
Balance sheet
20252024202320222021
Cash and short-term investments$17M$24.3M$6.06M$2.08M$5.19M
Net receivables$123.1M$81.3M$61.1M$53.4M$53.9M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$167.4M$122.9M$80.1M$73.8M$75.8M
Property, plant and equipment, net$336.9M$313.9M$291.5M$287.5M$317.8M
Goodwill and intangible assets$436.7M$225.3M$158.8M$138.1M$128M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$800.8M$556.7M$459.6M$438.3M$454.5M
Total assets$968.2M$679.5M$539.7M$512.1M$530.3M
Accounts payable$25.2M$18.7M$10.8M$13.7M$10.6M
Short-term debt$30M$19.7M$17.1M$16.6M$16.1M
Deferred revenue$2.29M$2.28M$1.66M$1.59M$7.67M
Total current liabilities$147.3M$101.7M$71.6M$70.3M$71.6M
Long-term debt$423.2M$253.4M$312.5M$309.9M$339.1M
Deferred revenue, non-current$0.00$0.00$0.00$0.00-$-88.21M
Total non-current liabilities$446.7M$265.9M$322.6M$316.2M$344.4M
Capital lease obligations$279.3M$273.1M$265.7M$263.7M$303.9M
Total liabilities$593.9M$367.6M$394.2M$386.5M$416.1M
Common stock$40K$40K$30K$30K$30K
Retained earnings$86.8M$57.2M$34.7M$21.3M$14.6M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$374.3M$312M$145.5M$125.7M$114.2M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$453.2M$273.1M$329.6M$326.6M$355.2M
Net debt$436.1M$248.8M$323.6M$324.5M$350.1M
Cash flow statement
20252024202320222021
Net income$33.8M$24.3M$13.9M$7.24M$2.15M
Depreciation and amortization$8.54M$6.12M$5.13M$4.9M$4.78M
Stock-based compensation$8.94M$7.78M$5.37M$3.09M$10M
Change in working capital-$-1.59M$930K$3.44M-$-9.5M-$-37.38M
Accounts receivable-$-24.15M-$-21.09M-$-7.35M-$-360K-$-7.33M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$5.8M$8.05M-$-1.84M$2.37M$560K
Net cash provided by operating activities$48.3M$39.3M$33.1M$9.04M-$-18.22M
Investments in property, plant and equipment-$-22M-$-8.99M-$-8.11M-$-14.17M-$-6.3M
Acquisitions, net-$-204.02M-$-48.42M-$-21.38M-$-10.13M-$-13.55M
Net cash used for investing activities-$-227.97M-$-70.68M-$-30.22M-$-24.24M-$-20.12M
Common stock issued$550K$119M$580K$1.08M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$172.5M$49.6M$1.11M$12.1M$43.5M
Net change in cash-$-7.22M$18.2M$3.98M-$-3.11M$5.15M
Cash at end of period$17M$24.3M$6.06M$2.08M$5.19M
Operating cash flow$48.3M$39.3M$33.1M$9.04M-$-18.22M
Capital expenditure-$-22M-$-8.99M-$-8.11M-$-14.17M-$-6.3M
Free cash flow$26.3M$30.3M$25M-$-5.13M-$-24.53M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About The Pennant Group, Inc.

        The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.

        CEO
        Brent J. Guerisoli
        Employees
        9.7K
        Beta
        1.25

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of The Pennant Group, Inc. (PNTG)?

        The Pennant Group, Inc. (PNTG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is PNTG undervalued?

        PNTG trades at a price of $34.64 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.